Gabos; Balint
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gabos; Balint.The latest application filed is for "novel amide compounds".
- Gabos; Balint - Cheshire GB
- Gabos; Balint - Lund SE
- Gabos; Balint - AstraZeneca R&D Lund SE
| Patent | Date |
|---|---|
| Novel Amide Compounds App 20130237507 - Burkamp; Frank ; et al. | 2013-09-12 |
| Compounds Grant 8,338,587 - Burkamp , et al. December 25, 2 | 2012-12-25 |
| Chemical Compounds 572 App 20120252770 - Berger; Markus ; et al. | 2012-10-04 |
| Novel Compounds App 20120232101 - Chapman; David ; et al. | 2012-09-13 |
| Novel Compounds App 20120178726 - Bladh; Hakan ; et al. | 2012-07-12 |
| Hydantoin compounds and pharmaceutical compositions thereof Grant 8,183,251 - Chapman , et al. May 22, 2 | 2012-05-22 |
| Glucocorticosteroids, processes for their preparation, pharmaceutical compositions containing them and their use in therapy Grant 8,163,724 - Bladh , et al. April 24, 2 | 2012-04-24 |
| Chemical compounds 572 Grant 8,143,290 - Berger , et al. March 27, 2 | 2012-03-27 |
| Chemical Compounds App 20120065173 - Berger; Markus ; et al. | 2012-03-15 |
| Indazolyl sulphonamide derivatives useful as glucocorticoid modulators Grant 8,030,340 - Berger , et al. October 4, 2 | 2011-10-04 |
| Hydantoin derivatives for the treatment of obstructive airway diseases Grant 7,989,620 - Gabos , et al. August 2, 2 | 2011-08-02 |
| Chemical Compounds 572 App 20110071194 - Berger; Markus ; et al. | 2011-03-24 |
| Novel Hydantoin Derivatives as Metalloproteinase Inhibitors App 20100256166 - Gabos; Balint ; et al. | 2010-10-07 |
| Novel Amide Compounds App 20100256104 - Burkamp; Frank ; et al. | 2010-10-07 |
| Novel Compounds App 20100256103 - Burkamp; Frank ; et al. | 2010-10-07 |
| Chemical Compounds 572 App 20100197644 - Berger; Markus ; et al. | 2010-08-05 |
| Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases App 20100144771 - Gabos; Balint ; et al. | 2010-06-10 |
| Chemical compounds 572 Grant 7,728,030 - Berger , et al. June 1, 2 | 2010-06-01 |
| Hydantoin derivatives as metalloproteinase inhibitors Grant 7,700,604 - Gabos , et al. April 20, 2 | 2010-04-20 |
| Hydantoin derivatives as metalloproteinase inhibitors Grant 7,655,664 - Gabos , et al. February 2, 2 | 2010-02-02 |
| Hydantoin derivatives for the treatment of obstructive airway diseases Grant 7,648,992 - Gabos , et al. January 19, 2 | 2010-01-19 |
| Novel Compounds App 20090286835 - BLADH; Hakan ; et al. | 2009-11-19 |
| Novel Hydantoin Derivatives as Metalloproteinase Inhibitors App 20080293743 - Gabos; Balint ; et al. | 2008-11-27 |
| Novel Compounds App 20080221139 - Chapman; David ; et al. | 2008-09-11 |
| Chemical compounds 572 App 20080214641 - Berger; Markus ; et al. | 2008-09-04 |
| Chemical compounds App 20080207721 - Berger; Markus ; et al. | 2008-08-28 |
| Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases App 20080064710 - Gabos; Balint ; et al. | 2008-03-13 |
| Novel Hydantoin Derivatives as Metalloproteinase Inhibitors App 20080032997 - Gabos; Balint ; et al. | 2008-02-07 |
| Compounds App 20080004317 - Gabos; Balint ; et al. | 2008-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 